Видео ютуба по тегу Kyverna Therapeutics Update

Kyverna Therapeutics
Kyverna Therapeutics
Kyverna Therapeutics KOL Event on Neuroimmunology CAR T Franchise in SPS and MG | Aug 28, 2025
Kyverna Therapeutics KOL Event on Neuroimmunology CAR T Franchise in SPS and MG | Aug 28, 2025
Warner Biddle, CEO, Kyverna Therapeutics | Onyx @ Jefferies | London Life Sciences Week 2025
Warner Biddle, CEO, Kyverna Therapeutics | Onyx @ Jefferies | London Life Sciences Week 2025
Behind the Bell: Kyverna Therapeutics
Behind the Bell: Kyverna Therapeutics
The Disease-Clearing Potential of CAR T-Cell Therapy for Autoimmune Diseases | BMWS25 Case Study
The Disease-Clearing Potential of CAR T-Cell Therapy for Autoimmune Diseases | BMWS25 Case Study
Warner Biddle: Building a commercial model for CAR-T in autoimmune care
Warner Biddle: Building a commercial model for CAR-T in autoimmune care
Kyverna Therapeutics
Kyverna Therapeutics
Kyverna Therapeutics Topline KYSA 8 Topline Results for Stiff Person Syndrome
Kyverna Therapeutics Topline KYSA 8 Topline Results for Stiff Person Syndrome
The Evolution of CAR-T from Niche Treatment to Mainstream Care
The Evolution of CAR-T from Niche Treatment to Mainstream Care
Kyverna Therapeutics Data from KYSA 6 Study of KYV 101 in Generalized Myasthenia Gravis | Oct 29/25
Kyverna Therapeutics Data from KYSA 6 Study of KYV 101 in Generalized Myasthenia Gravis | Oct 29/25
KYTX Stock Analysis (Kyverna Therapeutics Stock) December 15, 2025
KYTX Stock Analysis (Kyverna Therapeutics Stock) December 15, 2025
CAR T cell therapy Lupus trial success
CAR T cell therapy Lupus trial success
Kyverna Class Action Lawsuit - Investors Allege Adverse Data About Clinical Trials Not Disclosed
Kyverna Class Action Lawsuit - Investors Allege Adverse Data About Clinical Trials Not Disclosed
KYTX Kyverna Therapeutics: Tuesday Predicted Opening Price After $100M Offering & Breakthrough Data
KYTX Kyverna Therapeutics: Tuesday Predicted Opening Price After $100M Offering & Breakthrough Data
Revolutionizing Myasthenia Gravis Treatment: KYV-101 CAR-T Therapy
Revolutionizing Myasthenia Gravis Treatment: KYV-101 CAR-T Therapy
Kyverna Impact2024
Kyverna Impact2024
MAJOR BREAKOUT | $KYTX STOCK ANALYSIS | KYVERNA THERAPEUTICS STOCK
MAJOR BREAKOUT | $KYTX STOCK ANALYSIS | KYVERNA THERAPEUTICS STOCK
Webinar: A New Approach to Treating Generalized Myasthenia Gravis: KYY-101 CAR T-cell Therapy
Webinar: A New Approach to Treating Generalized Myasthenia Gravis: KYY-101 CAR T-cell Therapy
KYTX STOCK : PRICE RECOVERY | KYVERNA THERAPEUTICS STOCK
KYTX STOCK : PRICE RECOVERY | KYVERNA THERAPEUTICS STOCK
KYTX Stock (Kyverna Therapeutics, Inc.) KYTX Stock Analysis | December 24, 2025
KYTX Stock (Kyverna Therapeutics, Inc.) KYTX Stock Analysis | December 24, 2025